New research on gut-to-brain signaling uncovers potential links between gut hormones like GLP-1 and longevity.
In a recent study published in PNAS, researchers from Brown University have made strides in understanding how gut hormones, specifically neuropeptide F (NPF), regulate aging in Drosophila melanogaster (fruit flies). The implications of this research are significant as it sheds light on gut-brain interactions, suggesting that human incretin hormones, such as glucagon-like peptide-1 (GLP-1), might play a similar role in influencing aging and healthspan [1].
Longevity.Technology: The gut-brain axis has long been a subject of interest in lifespan research, and GLP-1 agonists, already used in the treatment of obesity and diabetes, are showing promise in the field of healthspan therapeutics. These drugs mimic the incretin GLP-1, a gut-derived hormone that enhances insulin secretion. While this role of incretins in metabolism is clear, their connection to aging, as suggested by this study, requires further exploration, especially in light of the differences between Drosophila and humans.
In their study, lead author Marc Tatar and his team focused on NPF, an insulin-regulatory hormone secreted by the gut in response to diet. They discovered that suppressing NPF in flies’ intestines led to a significant extension of lifespan, largely due to its regulation of insulin and juvenile hormone (JH) – a key factor in the aging process in flies [1].
“We showed how all of these things work together to control lifespan,” Tatar noted, highlighting the complex interplay between gut-derived hormones, brain signaling and longevity. The research provides new insights into how gut hormones influence insulin production and juvenile hormone (JH) levels, both of which are critical to the aging process in flies [1].
The researchers mapped NPF production from the gut to the brain, where it affects insulin-secreting neurons. These neurons also regulate the secretion of juvenile hormone, a key factor in the aging of Drosophila. When NPF secretion was reduced, insulin and juvenile hormone levels dropped, leading to increased lifespan. Conversely, increased NPF production, which leads to higher insulin and JH levels, is hypothesized to have negative effects on aging and longevity [1].
The findings highlight the conservation of biological mechanisms between flies and humans, especially regarding insulin and gut hormones. While humans do not produce NPF, they do produce analogous incretins like GLP-1, which regulate insulin production in a similar fashion. This raises the possibility that incretin-based treatments, such as GLP-1 agonists used in diabetes therapies, might influence human aging processes.
“The fly is an excellent model for humans, but we need to progress the research from flies to mice and set up studies that look at GLP-1 agonists and aging,” said Tatar. Importantly, the researchers also noted significant differences between how males and females responded to NPF manipulation, a point that highlights the complexity of hormonal regulation in aging [1].
As small and simple as flies may seem, they share many genetic similarities with humans, including the signaling pathways that regulate insulin and other hormones. Given that incretins have already revolutionized diabetes management, their potential application in longevity research is a natural next step. However, the distinct pathways in Drosophila that involve juvenile hormone, which has no direct analog in humans, suggest that much more research is needed to determine how these findings could be applied to human aging.
In the context of this emerging field, the gut-brain axis is becoming increasingly recognized as a central player in metabolic regulation and aging. Gut hormones, like GLP-1, not only control insulin secretion but also influence brain function, suggesting a bidirectional relationship between gut health and overall aging. The potential for incretin-based therapies to extend lifespan or improve healthspan by modulating insulin pathways is clearly an area warranting further research.
It will be necessary to explore how gut hormones like GLP-1 might affect human aging, particularly through their impact on insulin signaling. The longevity effects observed in flies, while compelling, require validation in mammalian models. The role of juvenile hormone, which is specific to insects, further complicates direct translation to humans but offers an interesting model for understanding hormonal control of aging.
With incretins already playing a key role in managing metabolic diseases, their potential to extend healthspan could mark a significant shift in how we approach aging and age-related conditions. As research continues to evolve, it would not be surprising if the role of GLP-1 and other gut hormones in longevity proves to be a critical area of focus for future therapeutics.
[1] https://www.pnas.org/doi/10.1073/pnas.2411987121
